BD News Archive

2014

February

Media Release / Feb 28, 2014

Novartis marks Rare Disease Day with call for more research to understand and find treatments for rare diseases

Media Release / Feb 26, 2014

Novartis extends leadership in clinical trial data transparency, reinforcing its support of clinical research and innovation

Novartis achieves Silver Class status in RobecoSAM's 2014 sustainability ranking

Novartis is proud to have achieved Silver Class status in this year’s edition of the RobecoSAM “Sustainability Yearbook” for our excellent sustainability performance.

Media Release / Feb 25, 2014

Novartis shareholders approve all resolutions proposed by Novartis Board of Directors

Media Release / Feb 24, 2014

Novartis provides second US university with Bexsero® to help protect students and staff against potentially deadly meningitis B disease

Media Release / Feb 21, 2014

Novartis shows continued commitment in Japan with Lucentis® approval in fourth Japanese indication, diabetic macular edema

Media Release / Feb 19, 2014

Novartis investigational compound LDE225 met primary endpoint in pivotal trial for patients with advanced basal cell carcinoma

- TwitterTweet
- FacebookShare
- Share
  - Twitter
  - Facebook
  - LinkedIn
  - Google +
  - Email
- Jump to Comments
Print
Save